Hyperbaric oxygen therapy for neuropathy
Hyperbaric Oxygen Therapy (HBOT) is an effective treatment for neuropathy, which drives oxygen deep into tissues and reduces cell death and pain symptoms. It also stimulates the growth of new blood vessels, enabling the body to increase effective oxygen and nutrient delivery.
HBOT is a medical treatment that uses pure oxygen to speed and enhance the body’s natural ability to heal. While sometimes hyperbaric medicine procedures are used as a primary emergency treatment, it is more often used as a cost effective adjunct or enhancement therapy. This therapy is recommended as an adjuvant therapy for diabetic neuropathy.
With the rise in diabetes mellitus type II, neuropathy and olfactory dysfunction, are becoming increasingly common among population. Thus, the purpose of this study was to evaluate olfactory dysfunction and effectiveness of this treatment in patients with type 2 diabetic neuropathy.
All patients included in the group 1 were diagnosed with diabetes mellitus type II and diabetic neuropathy, were administered with a hyperbaric oxygen therapy for 30 sessions. Group 2 included patients who returned for a check up following 30 sessions and group 3 had healthy volunteers as a control group. To evaluate the olfactory function, connecticut chemosensory clinical research test and the subjective visual analog scale were utilized. The results of the study depicted statistically significant difference in both groups before and after the HBOT.
HBOT is becoming increasingly recognized as a potential treatment modality for a broad range of ailments, including olfactory dysfunctions. Additionally, this is the first study demonstrating that the HBO therapy can play a role in treating olfactory dysfunctions suffered by the patients with diabetic olfactory neuropathies as statistically significant improvements have been seen in the study.